Company Comparison
Juno Therapeutics vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Juno Therapeutics | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | — |
| Founded | 2013 | — |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | $300M | — |
| Valuation | — | — |
What They Build
Juno Therapeutics
Juno Therapeutics, Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Shared Investors
1 firm has invested in both Juno Therapeutics and 10x Genomics.
Sector Overlap
Both Juno Therapeutics and 10x Genomics operate in Biotech.
Browse all Biotech companies →